Company News

Report on InnoVax Forum 2017

Time: 2019/7/13 14:55:14      Views: 154


Deliver Life Sciences is pleased to bring the InnoVax Forum 2017 (Vaccine Development and Manufacturing Forum) has been successfully convened at Renaissance Yu Garden Shanghai Hotel from Nov.15-16. 2017. InnoVax Forum 2017 has received the official support from SAPA-GP (Sino-American Pharmaceutical Professionals Association- Greater Philadelphia) and has partnered with the global leading solution providers including GE Life Sciences, Gamma Vaccines, CMIC, Schreiner MediPharm, Healthgen Biotechnology.


Selected Presentations

The Future Landscape of Vaccine Product Development

Margaret Liu, Principal, ProTherImmune; President of International Society of Vaccines


Future Prospectus and Application for the Development of Adenovirus-based Vaccine

Xuefeng Yu, President and CEO, CanSinoBio


NeoAntigen Based Cancer Vaccine: a brighter Future of Cancer Immunotherapy

John Wang, CEO, ImmuOn Therapeutics


Build External Partnership for Vaccine Research and Development

Sean Du, Head, External R&D, Asia Pacific, Global R&D, Sanofi Pasteur


New Technologies and Platform for Vaccine R&D

Pele Chong, Senior Vice President, Vaccine R&D, United Biomedical


Vaccine Immune Correlates of Protection

Charles Sia, Chief Technical Officer, Vaccine R&D, BravoVax


Antibody-dependent enhancement of Zika Virus Infection

Xia Jin, Professor, Principal Investigator, Associate Director, CAS, Key Laboratory of Molecular Virology and Immunology, Chief, Viral Disease and Vaccine Translational Research Unit, Institut Pasteur of Shanghai, CAS


Therapeutic Vaccine Development against Chronic Hepatitis B virus Infection

Jung-Sun Yum, Executive Director, R&D Centre, CHA Vaccine Institute


Issues, Opportunities and Challenges for TB Vaccine Research and Development

Honghai Wang, Professor, Director of Academic Committee of Shanghai Key Laboratory of Tuberculosis, Vice Director of Institute of Genetics, Fudan University


Recombinant flagellin as mucosal adjuvant for development of mucosal vaccine

Huimin Yan, Professor, Director, Division of Viral Pathology, State Key Laboratory of Virology, Wuhan Institute of Virology, CAS


Global Market and Technology Trends in Vaccine BioProcessing

Guenter Jagschies, Senior Director, GE Life Sciences


The Use of Recombinant Human Albumin for Vaccine Production

Daichang Yang, President, Wuhan Healthgen Biotechnology Corp.


Evaluation of antibody quality elicited by a replication defective HCMV vaccine

Sha Ha, Director, Vaccine BioProcess R&D, Merck & Co., USA


QbD Tools to Accelerate BioProcess R&D and Support Vaccine Manufacturing

Chris Ladd, Senior Scientist, Purification Development Dept. Shanghai ZeRun Biotech


For more information about the conference proceedings and presentation manuscripts

please forward your enquiry to info@deliver-consulting.com